Please login to the form below

Not currently logged in
Email:
Password:

Antares appoints David Bergstrom as SVP

Second major appointment in one month

Antares Pharma has appointed Dr David Bergstrom as senior VP of pharmaceutical development.

Dr Bergstrom joins from Advantar Laboratories where he serves as executive VP and chief operating officer.

His previous roles included spells as chief operating office of NoveDel Pharmaceuticals and general manager of pharmaceutical development at Cardinal Health.

He is the second senior VP to join Antares this month after the appointment of former Pfizer VP Dr Bruce Freundlich as senior VP, medical.

The appointments come as the company looks to expand its business after the commercialisation of Otrexup (methotrexate) for arthritis and the advance in development of testosterone replacement therapy Vibex QS T.

Dr Paul Wotton, CEO of Antares, said: "David has a proven track record as a leader of product development teams and has worked on multiple FDA approved products including 505B2 drug/device combination programmes. His broad product development expertise will help drive our pipeline initiative."

20th November 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics